Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to

Condition:   Prevention of Swine InfluenzaIntervention:   Biological: Swine InfluenzaSponsors:   Novartis Vaccines;   NovartisCompleted - verified October 2014

Source: ClinicalTrials.gov - May 16, 2013 Category: Research Source Type: clinical trials